47
Auron Therapeutics, Inc. raises $7.1M under Reg D
Company raise · Raising · Offering $12M · Sold $7.1M · WELLESLEY, MA · filed 2026-08-13
27
Auron Therapeutics, Inc. files Form D
Company raise update · Raising · NEWTON, MA · Form D/A filed 2025-12-23
$10M+ raise
Why now — by persona
Relevant to: B2B software & services sales. Lead card pending.
People on the filing
| Briggs Duncan Morrison | Director |
| Pini Duncan Orbach | Director |
| Katharine Yen | Executive Officer, Director |
| Alexandra Cantley | Director |
| Victoria Duncan Richon | Director |
| Anna Duncan French | Director |
| Serge Duncan Messerlian | Director |
Signed by Katharine Yen, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
52
Auron Therapeutics, Inc. raises $13.4M under Reg D
Company raise · Raising · Offering $41.8M · Sold $13.4M · NEWTON, MA · filed 2024-12-31